Epidemiological trends in nontuberculous mycobacterial infection among people with cystic fibrosis in Germany

被引:4
|
作者
Steindor, Mathis [1 ]
Hafkemeyer, Sylvia [2 ]
Ruckes, Christian [3 ]
Stehling, Florian [1 ]
Naehrlich, Lutz [4 ]
Ringsha, Felix C. [5 ,6 ]
机构
[1] Univ Duisburg Essen, Childrens Univ Hosp Essen, Pediat Pulmonol & Sleep Med, Essen, Germany
[2] Mukoviszidose Inst gGmbH, Bonn, Germany
[3] Johannes Gutenberg Univ Mainz, Univ Med Ctr Johannes Gutenberg, Interdisciplinary Ctr Clin Trials Mainz, Mainz, Germany
[4] Justus Liebig Univ Giessen, Dept Pediat, Giessen, Germany
[5] German Ctr Lung Res DZL, Hannover Med Sch & Biomed Res End Stage & Obstruct, Dept Resp Med, Hannover, Germany
[6] European Reference Network Rare & Complex Resp Dis, Frankfurt, Germany
关键词
Cystic fibrosis transmembrane conductance; regulator; Epidemiology; Germany; Mycobacterium abscessus; Mycobacterium avium; Registries; PULMONARY-DISEASE; SCREENING PRACTICES; PREVALENCE;
D O I
10.1016/j.ijid.2023.01.032
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objectives: People with cystic fibrosis (pwCF) are at risk for infection with nontuberculous mycobacteria (NTM). The epidemiology and screening practice of NTM among pwCF in Germany are largely unknown and require investigation.Methods: We analyzed the data of the German Cystic Fibrosis Registry from 2016 to 2020 for NTM. The annual prevalence and incidence of any NTM, Mycobacterium abscessus complex (MABC), Mycobacterium avium complex (MAC), Mycobacterium gordonae , and other mycobacteria were determined and correlated to patient characteristics. Patients with incident MABC and MAC infection were compared.Results: The annual NTM prevalence and incidence remained stable between 7.53% and 8.76%, as well as 3.31% and 4.95%, respectively, among the approximately 60 0 0 registry participants. MABC was the most common NTM, whereas only the prevalence of MAC increased slightly. In each year, only about one-third of all patients were screened for NTM. An association between NTM infections and Aspergillus fumigatus infection and/or allergic bronchopulmonary aspergillosis was observed. On average, patients with incident MAC infection were older than patients with MABC infection.Conclusion: The NTM burden in pwCF in Germany remained unchanged between 2016 and 2020. MABC was the dominant species detected, whereas only MAC infections increased with time and patient age. The previously observed association of Aspergillus fumigatus and NTM was reaffirmed. Awareness of NTM needs to be improved.(c) 2023 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. This is an open access article under the CC BY license ( http://creativecommons.org/licenses/by/4.0/ )
引用
收藏
页码:32 / 39
页数:8
相关论文
共 50 条
  • [21] Nontuberculous Mycobacteria Pulmonary Infection in Children with Cystic Fibrosis
    Hussain, Sabiha R.
    Said, Amira M.
    Starke, Jeffrey R.
    CURRENT INFECTIOUS DISEASE REPORTS, 2024, 26 (10) : 217 - 226
  • [22] Tissue-localized immune responses in people with cystic fibrosis and respiratory nontuberculous mycobacteria infection
    Hayes, Don, Jr.
    Shukla, Rajni Kant
    Cheng, Yizi
    Gecili, Emrah
    Merling, Marlena R.
    Szczesniak, Rhonda D.
    Ziady, Assem G.
    Woods, Jason C.
    Hall-Stoodley, Luanne
    Liyanage, Namal P. M.
    Robinson, Richard T.
    JCI INSIGHT, 2022, 7 (12)
  • [23] Phylogenomics of nontuberculous mycobacteria respiratory infections in people with cystic fibrosis
    Bolden, Nicholas
    Mell, Joshua Chang
    Logan, Jennifer Bouso
    Planet, Paul J.
    PAEDIATRIC RESPIRATORY REVIEWS, 2023, 46 : 63 - 70
  • [24] Nontuberculous Mycobacterial Lung Disease in the Patients with Cystic Fibrosis-A Challenging Diagnostic Problem
    Wyrostkiewicz, Dorota
    Opoka, Lucyna
    Filipczak, Dorota
    Jankowska, Ewa
    Skorupa, Wojciech
    Augustynowicz-Kopec, Ewa
    Szturmowicz, Monika
    DIAGNOSTICS, 2022, 12 (07)
  • [25] Epidemiology of Pulmonary Nontuberculous Mycobacterial Sputum Positivity in Patients with Cystic Fibrosis in the United States, 2010-2014
    Adjemian, Jennifer
    Olivier, Kenneth N.
    Prevots, D. Rebecca
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2018, 15 (07) : 817 - 826
  • [26] Trends in nontuberculous mycobacterial disease in hospitalized subjects in Spain (1997-2010) according to HIV infection
    Alvaro-Meca, A.
    Rodriguez-Gijon, L.
    Diaz, A.
    Gil, A.
    Resino, S.
    HIV MEDICINE, 2015, 16 (08) : 485 - 493
  • [27] Nontuberculous Mycobacteria among Patients with Cystic Fibrosis in the United States Screening Practices and Environmental Risk
    Adjemian, Jennifer
    Olivier, Kenneth N.
    Prevots, D. Rebecca
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 190 (05) : 581 - 586
  • [28] Epidemiological trends and clinical relevance of nontuberculous mycobacterial pulmonary disease in a referral hospital in Japan, 2017-2021
    Ito, Masashi
    Furuuchi, Koji
    Fujiwara, Keiji
    Kodama, Tatsuya
    Tanaka, Yoshiaki
    Yoshiyama, Takashi
    Ogata, Hideo
    Kurashima, Atsuyuki
    Ohta, Ken
    Morimoto, Kozo
    RESPIRATORY INVESTIGATION, 2024, 62 (06) : 1064 - 1071
  • [29] Atypical mycobacterial infection in patients with cystic fibrosis: update on clinical microbiology methods
    Jordan, P. W.
    Stanley, T.
    Donnelly, F. M.
    Elborn, J. S.
    McClurg, R. B.
    Millar, B. C.
    Goldsmith, C. E.
    Moore, J. E.
    LETTERS IN APPLIED MICROBIOLOGY, 2007, 44 (05) : 459 - 466
  • [30] Healthcare-associated links in transmission of nontuberculous mycobacteria among people with cystic fibrosis (HALT NTM) study: Rationale and study design
    Gross, Jane E.
    Caceres, Silvia
    Poch, Katie
    Hasan, Nabeeh A.
    Davidson, Rebecca M.
    Epperson, L. Elaine
    Lipner, Ettie
    Vang, Charmie
    Honda, Jennifer R.
    Strand, Matthew
    Strong, Michael
    Saiman, Lisa
    Prevots, D. Rebecca
    Olivier, Kenneth N.
    Nick, Jerry A.
    PLOS ONE, 2021, 16 (12):